Safety and Efficacy of ALXN1720 in Adults With Generalized Myasthenia Gravis

NCT05556096 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

261

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Myasthenia Gravis

Interventions

COMBINATION_PRODUCT: ALXN1720
COMBINATION_PRODUCT: Placebo

Sponsor

Alexion Pharmaceuticals, Inc.